September 13, 2018: The US Patent Office has issued U.S. Patent No. 10,064,616 (http://bit.ly/SUTUREGARDpatent) entitled “VARIABLE STIFFNESS SUTURE BRIDGES COMPATIBLE WITH VARIOUS SUTURE PATTERNS” to SUTUREGARD™ Medical, Inc.
March 30, 2018: Dan Ladizinsky, MD assumes CEO position at SUTUREGARD™ Medical .
March 27, 2018: Effective immediately, JULIVA™ Technologies Inc will go by the name “SUTUREGARD™ Medical” operating under JULVIA™ Technologies Inc. The move to a new name was a branding decision. SUTUREGARD™ is a more intuitive reference to our product line-up.
November 15, 2017: OSU Venture Development Fund invests in JULVIA™ Technologies Inc.
JULVIA™ Technologies Inc Wins Business Oregon Grant
JULVIA™ Technologies Inc Wins Synapse MedTech Pitch Competition